Predicting complications of diabetes mellitus using advanced machine learning algorithms

OBJECTIVE We sought to predict if patients with type 2 diabetes mellitus (DM2) would develop 10 selected complications. Accurate prediction of complications could help with more targeted measures that would prevent or slow down their development. MATERIALS AND METHODS Experiments were conducted on the Healthcare Cost and Utilization Project State Inpatient Databases of California for the period of 2003 to 2011. Recurrent neural network (RNN) long short-term memory (LSTM) and RNN gated recurrent unit (GRU) deep learning methods were designed and compared with random forest and multilayer perceptron traditional models. Prediction accuracy of selected complications were compared on 3 settings corresponding to minimum number of hospitalizations between diabetes diagnosis and the diagnosis of complications. RESULTS The diagnosis domain was used for experiments. The best results were achieved with RNN GRU model, followed by RNN LSTM model. The prediction accuracy achieved with RNN GRU model was between 73% (myocardial infarction) and 83% (chronic ischemic heart disease), while accuracy of traditional models was between 66% - 76%. DISCUSSION The number of hospitalizations was an important factor for the prediction accuracy. Experiments with 4 hospitalizations achieved significantly better accuracy than with 2 hospitalizations. To achieve improved accuracy deep learning models required training on at least 1000 patients and accuracy significantly dropped if training datasets contained 500 patients. The prediction accuracy of complications decreases over time period. Considering individual complications, the best accuracy was achieved on depressive disorder and chronic ischemic heart disease. CONCLUSIONS The RNN GRU model was the best choice for electronic medical record type of data, based on the achieved results.

[1]  Riccardo Bellazzi,et al.  Machine Learning Methods to Predict Diabetes Complications , 2018, Journal of diabetes science and technology.

[2]  C. Mann,et al.  Observational research methods. Research design II: cohort, cross sectional, and case-control studies , 2003, Emergency medicine journal : EMJ.

[3]  J. Plutzky,et al.  The pathologic continuum of diabetic vascular disease. , 2009, Journal of the American College of Cardiology.

[4]  M. de Groot,et al.  Diabetes and Depression , 2014, Current Diabetes Reports.

[5]  Jimeng Sun,et al.  Using recurrent neural network models for early detection of heart failure onset , 2016, J. Am. Medical Informatics Assoc..

[6]  Emily Gammoh,et al.  Update on Management of Type 2 Diabetes for Cardiologists. , 2018, Methodist DeBakey cardiovascular journal.

[7]  Irl B Hirsch,et al.  AACE/ACE Consensus Statement CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY , 2018 .

[8]  Fei Wang,et al.  Deep Learning in Medicine-Promise, Progress, and Challenges. , 2019, JAMA internal medicine.

[9]  James L. McClelland,et al.  Parallel distributed processing: explorations in the microstructure of cognition, vol. 1: foundations , 1986 .

[10]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[11]  J. McGill,et al.  Diabetic Kidney Disease. , 2016, Missouri medicine.

[12]  Philipp Slusallek,et al.  Introduction to real-time ray tracing , 2005, SIGGRAPH Courses.

[13]  Brian Caffo,et al.  Mixed effect machine learning: A framework for predicting longitudinal change in hemoglobin A1c , 2019, J. Biomed. Informatics.

[14]  Eva L Feldman,et al.  Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.

[15]  Angelo Galiano,et al.  LSTM DSS Automatism and Dataset Optimization for Diabetes Prediction , 2019, Applied Sciences.

[16]  Ronald J. Williams,et al.  A Learning Algorithm for Continually Running Fully Recurrent Neural Networks , 1989, Neural Computation.

[17]  R. McCoy,et al.  Benefits and harms of intensive glycemic control in patients with type 2 diabetes , 2019, BMJ.

[18]  C. Bailey,et al.  Treatment of type 2 diabetes: future approaches , 2018, British medical bulletin.

[19]  A. Laub,et al.  The singular value decomposition: Its computation and some applications , 1980 .

[20]  T. Maddox,et al.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. , 2015, World journal of diabetes.

[21]  Amir Hayeri,et al.  Predicting Future Glucose Fluctuations Using Machine Learning and Wearable Sensor Data , 2018, Diabetes.

[22]  Dan McDermott,et al.  Hearing Impairment in Relation to Severity of Diabetes in a Veteran Cohort , 2015, Ear and hearing.

[23]  J. Vehí,et al.  Artificial Intelligence for Diabetes Management and Decision Support: Literature Review , 2018, Journal of medical Internet research.

[24]  Jennifer K. Sun,et al.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. , 2017, JCI insight.